We appreciate your patience. Your content is on the way.
SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Paushak Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Paushak Limited established in May, 1972, is part of the "Alembic Group" having a legacy of more than 115 years. Alembic Limited, the first company of Alembic Group, was established in 1907 in Vadodara, Gujarat, India and is the oldest Pharmaceutical Company in India. Paushak Limited is India`s largest Phosgene based Specialty chemical manufacturer with core competencies in Isocyanates, Chloroformates, Carbamoyl Chlorides, Carbamates, Protecting agents etc. Paushak si an India-based dealing in Speciality Chemicals Business. The Company is engaged in the production of phosgene gas and phosgene-based specialty chemicals/ intermediates. Its products include isocyanates, chloroformates, carbamoyl chlorides, substituted urea, acid chlorides, carbonates, carbamates and others. These chemicals are used in diverse fields, such as pesticides, pharmaceuticals, dyes, plastics and perfumeries. Paushak has proven track record of production & safe handling of Phosgene & its derivatives for ~55 years while running its operations at its site at Panchmahal district near to Vadodara, Gujarat, India since 1979. The site is "Responsible Care" certified where Paushak operates state of the art Phosgene Plant of 14400 MT/Year with global benchmarks for operational efficiencies, process safety including EHS with additional downstream multipurpose Phosgene derivatives plants. The Company undertakes toll/contract manufacturing for phosgenation to produce carbamoyl chloride, isocyanate, choloformate and urea. The Company is part of the Alembic Group from Baroda, India. Its associate companies include Alembic Ltd., Shreno Ltd., Nirayu Private Ltd., Whitefield Chemtech Pvt. Ltd., Sierra Investment Ltd. and Viramya Packlight Ltd. The Company has production capacity of 150 tons per month of phosgene with a turnover of USD 3.5 Million p.a. with a workforce of 200 plus. It has an in-house process development and R & D laboratory. It also has Corporate support in Production, R&D, QA, etc.
Paushak share price as on 13 Jun 2025 is Rs. 4400. Over the past 6 months, the Paushak share price has decreased by 15.39% and in the last one year, it has decreased by 21.29%. The 52-week low for Paushak share price was Rs. 3746 and 52-week high was Rs. 6385.
532742
INE111F01016
Aug
Paushak Ltd FAQs
You can buy Paushak Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Paushak Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 13, 2025 04:01 PM the closing price of Paushak Ltd was Rs.4,400.00.
The latest PE ratio of Paushak Ltd as of Jun 13, 2025 04:01 PM is 27.38
The latest PB ratio of Paushak Ltd as of Jun 13, 2025 04:01 PM is 0.34
The 52-week high of Paushak Ltd share price is Rs. 6,385.00 while the 52-week low is Rs. 3,746.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 13, 2025 04:01 PM, the market cap of Paushak Ltd stood at Rs. 1,356.08 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.